All posts

Galaxy Digital Holdings is undervalued, this analyst says

Galaxy Digital Holdings (Galaxy Digital Holdings Stock Quote, Chart, News, Analysts, Financials TSXV:GLXY) may have posted a wider-than-expected loss in the first quarter of 2025, but ATB Capital Markets says brighter days are ahead, driven by its growing high-performance computing (HPC) business and a long-awaited U.S. stock listing.

In a May 13 update, ATB analyst Martin Toner reiterated his “Outperform” rating and held firm on a 12-month price target of $42.00, pointing to improving fundamentals and major upcoming milestones for the company.

“GLXY has been pursuing a Nasdaq listing for over four years,” Toner said. “As of May 13, the reorganization is complete, and GLXY intends to list on the Nasdaq on May 16, 2026. We see this as a positive catalyst for the stock as it unlocks a new cohort of U.S. investors, enables index and passive ownership, and provides more liquidity.”

The company reported a net loss of $295-million in Q1/25, falling short of expectations due to weaker digital asset prices and a softer performance in its lending operations. But Galaxy is already seeing a rebound, with Q2 operating income tracking between $160–170-million, helped by stronger crypto markets.

Galaxy’s 15-year, $4.5-billion hosting agreement with AI cloud player CoreWeave is a key driver of future growth. The deal underpins the buildout of Galaxy’s Helios data center, with Phase I expected to go live in the first half of 2026 and Phase II in 2027. ATB values the HPC segment alone at $18.02 per share, a major component of the firm’s bullish target.

While near-term earnings remain volatile, Toner sees long-term upside supported by infrastructure expansion, new investor access via Nasdaq, and continued momentum in both the crypto and AI compute markets.

-30-

Tagged with: glxy
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Is Organigram stock a buy?

Organigram (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) reported fiscal Q3 2025 results for the period ended June… [Read More]

2 days ago

Electrovaya is a buy, this analyst says

Electrovaya (Electrovaya Stock Quote, Chart, News, Analysts, Financials NASDAQ:ELVA) delivered strong fiscal Q3 2025 results, its second GAAP-profitable quarter and… [Read More]

3 days ago

Leede trims price target on Medexus Pharmaceuticals

Leede Financial analyst Douglas Loe said Aug. 13 that Medexus Pharmaceuticals’ (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP)… [Read More]

3 days ago

Hydreight Technologies is “Shopify for healthcare”, this analyst says

Beacon Securities analyst Gabriel Leung noted in an August 12 watchlist update that Hydreight Technologies (Hydreight Technologies Stock Quote, Chart,… [Read More]

3 days ago

Is Eupraxia Pharmaceuticals a buy?

Research Capital’s Andre Uddin said August 13 he remains focused on Eupraxia Pharmaceuticals’ (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts,… [Read More]

3 days ago

Altus Group upgraded at National Bank

National Bank Financial Markets analyst Richard Tse said Aug. 12 that reports of Altus Group (Altus Group Stock Quote, Chart,… [Read More]

3 days ago